anmelden
SLI
2.297,53
PKT
-6,73
PKT
-0,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.11.21 | Roche Neutral | UBS AG | |
| 04.11.21 | Nestlé Hold | Jefferies & Company Inc. | |
| 03.11.21 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 02.11.21 | Holcim Buy | Deutsche Bank AG | |
| 01.11.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.11.21 | Holcim Buy | UBS AG | |
| 01.11.21 | UBS Outperform | RBC Capital Markets | |
| 01.11.21 | Holcim Outperform | Credit Suisse Group | |
| 01.11.21 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.10.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 29.10.21 | Swiss Re Sell | UBS AG | |
| 29.10.21 | Swiss Re Hold | Jefferies & Company Inc. | |
| 28.10.21 | Holcim Buy | Deutsche Bank AG | |
| 28.10.21 | UBS Buy | Jefferies & Company Inc. | |
| 27.10.21 | UBS Equal-weight | Morgan Stanley | |
| 27.10.21 | UBS Outperform | RBC Capital Markets | |
| 27.10.21 | Novartis Underweight | Barclays Capital | |
| 27.10.21 | UBS Underweight | Barclays Capital | |
| 27.10.21 | Novartis Sell | Deutsche Bank AG | |
| 27.10.21 | UBS Buy | Deutsche Bank AG | |
| 27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.21 | UBS Outperform | Credit Suisse Group | |
| 27.10.21 | Novartis Neutral | Credit Suisse Group | |
| 26.10.21 | UBS Buy | Jefferies & Company Inc. | |
| 26.10.21 | Swiss Re Halten | DZ BANK | |
| 26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.10.21 | Novartis Buy | UBS AG | |
| 26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.21 | Novartis Sell | Deutsche Bank AG | |
| 26.10.21 | Roche Buy | Deutsche Bank AG | |
| 26.10.21 | UBS Underweight | Barclays Capital | |
| 26.10.21 | UBS Outperform | RBC Capital Markets | |
| 26.10.21 | UBS Overweight | JP Morgan Chase & Co. | |
| 25.10.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.10.21 | Novartis Buy | UBS AG | |
| 25.10.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.21 | Nestlé Overweight | Barclays Capital | |
| 22.10.21 | ABB (Asea Brown Boveri) Buy | UBS AG |
